Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1999 May;80(3):F203–F208. doi: 10.1136/fn.80.3.f203

Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome

T Fok, K Lam, M Dolovich, P Ng, W Wong, K Cheung, K So
PMCID: PMC1720936  PMID: 10212082

Abstract

AIM—To investigate the therapeutic efficacy of inhaled fluticasone propionate, started on day 1 of age, on ventilated preterm infants with respiratory distress syndrome.
METHODS—Starting within 24 hours of age, ventilated preterm infants (gestation < 32 weeks, birthweight < 1.5 kg) with respiratory distress syndrome were given a 14 day course (two puffs, 12 hourly) of either fluticasone propionate (250 µg/puff) (group 1, n=27) or placebo (group 2, n=26) with a metered dose inhaler-spacer device. Response to treatment was assessed by the rate of successful extubation by days 7 and 14 of age, changes in respiratory system mechanics, death, occurrence of chronic lung disease, and other neonatal complications.
RESULTS—More infants in the treatment group were successfully extubated by 14 days of age than those in the placebo group (17/27 vs 8/26; p = 0.038). The treated infants also showed a more significant improvement in respiratory system compliance during the first 14 days of life. The two groups, however, did not differ significantly in their need for systemic steroids after day 14 of age, death, or the occurrence of chronic lung disease. The treatment was not associated with any increase in neonatal complications, including those attributable to steroid induced side effects.
CONCLUSION—These results provide preliminary evidence that early treatment with inhaled corticosteroids may be beneficial to ventilated preterm infants with respiratory distress. Further study of its use in a large scale randomised trial is warranted.



Full Text

The Full Text of this article is available as a PDF (139.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avery G. B., Fletcher A. B., Kaplan M., Brudno D. S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics. 1985 Jan;75(1):106–111. [PubMed] [Google Scholar]
  2. Barnes N. C., Marone G., Di Maria G. U., Visser S., Utama I., Payne S. L. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J. 1993 Jun;6(6):877–885. [PubMed] [Google Scholar]
  3. Cloutier M. M. Nebulized steroid therapy in bronchopulmonary dysplasia. Pediatr Pulmonol. 1993 Feb;15(2):111–116. doi: 10.1002/ppul.1950150208. [DOI] [PubMed] [Google Scholar]
  4. Cotterrell M., Balázs R., Johnson A. L. Effects of corticosteroids on the biochemical maturation of rat brain: postnatal cell formation. J Neurochem. 1972 Sep;19(9):2151–2167. doi: 10.1111/j.1471-4159.1972.tb05124.x. [DOI] [PubMed] [Google Scholar]
  5. Cummings J. J., D'Eugenio D. B., Gross S. J. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989 Jun 8;320(23):1505–1510. doi: 10.1056/NEJM198906083202301. [DOI] [PubMed] [Google Scholar]
  6. Dahl R., Lundback B., Malo J. L., Mazza J. A., Nieminen M. M., Saarelainen P., Barnacle H. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group. Chest. 1993 Nov;104(5):1352–1358. doi: 10.1378/chest.104.5.1352. [DOI] [PubMed] [Google Scholar]
  7. Fok T. F., Al-Essa M., Monkman S., Dolovich M., Girard L., Coates G., Kirpalani H. Pulmonary deposition of salbutamol aerosol delivered by metered dose inhaler, jet nebulizer, and ultrasonic nebulizer in mechanically ventilated rabbits. Pediatr Res. 1997 Nov;42(5):721–727. doi: 10.1203/00006450-199711000-00027. [DOI] [PubMed] [Google Scholar]
  8. Fok T. F., Lam K., Chan C. K., Ng P. C., Zhuang H., Wong W., Cheung K. L. Aerosol delivery to non-ventilated infants by metered dose inhaler: should a valved spacer be used? Pediatr Pulmonol. 1997 Sep;24(3):204–212. doi: 10.1002/(sici)1099-0496(199709)24:3<204::aid-ppul6>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  9. Fok T. F., Monkman S., Dolovich M., Gray S., Coates G., Paes B., Rashid F., Newhouse M., Kirpalani H. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 1996 May;21(5):301–309. doi: 10.1002/(SICI)1099-0496(199605)21:5<301::AID-PPUL5>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  10. Giep T., Raibble P., Zuerlein T., Schwartz I. D. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams. Am J Perinatol. 1996 Jan;13(1):5–9. doi: 10.1055/s-2007-994193. [DOI] [PubMed] [Google Scholar]
  11. Jones R., Wincott E., Elbourne D., Grant A. Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up. Pediatrics. 1995 Nov;96(5 Pt 1):897–906. [PubMed] [Google Scholar]
  12. Kamada A. K., Szefler S. J. Inhaled therapy in infants: why not nebulize glucocorticoids? Pediatr Pulmonol. 1992 Aug;13(4):198–199. doi: 10.1002/ppul.1950130403. [DOI] [PubMed] [Google Scholar]
  13. LaForce W. R., Brudno D. S. Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants. J Pediatr. 1993 Feb;122(2):285–288. doi: 10.1016/s0022-3476(06)80134-4. [DOI] [PubMed] [Google Scholar]
  14. Mammel M. C., Fiterman C., Coleman M., Boros S. J. Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up. Dev Pharmacol Ther. 1987;10(1):1–11. doi: 10.1159/000457722. [DOI] [PubMed] [Google Scholar]
  15. Merritt T. A., Cochrane C. G., Holcomb K., Bohl B., Hallman M., Strayer D., Edwards D. K., 3rd, Gluck L. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest. 1983 Aug;72(2):656–666. doi: 10.1172/JCI111015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Murch S. H., MacDonald T. T., Wood C. B., Costeloe K. L. Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax. 1992 Jan;47(1):44–47. doi: 10.1136/thx.47.1.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ng P. C., Fok T. F., Wong G. W., Lam C. W., Lee C. H., Wong M. Y., Lam K., Ma K. C. Pituitary-adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment. J Clin Endocrinol Metab. 1998 Jul;83(7):2390–2393. doi: 10.1210/jcem.83.7.4947. [DOI] [PubMed] [Google Scholar]
  18. Ng P. C. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child. 1993 Mar;68(3 Spec No):330–336. doi: 10.1136/adc.68.3_spec_no.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ng P. C., Thomson M. A., Dear P. R. Dexamethasone and infection in preterm babies: a controlled study. Arch Dis Child. 1990 Jan;65(1 Spec No):54–56. doi: 10.1136/adc.65.1_spec_no.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. O'Callaghan C., Hardy J., Stammers J., Stephenson T. J., Hull D. Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model. Arch Dis Child. 1992 Jan;67(1 Spec No):20–24. doi: 10.1136/adc.67.1_spec_no.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. O'Shea T. M., Kothadia J. M., Klinepeter K. L., Goldstein D. J., Jackson B., Dillard R. G. Follow-up of preterm infants treated with dexamethasone for chronic lung disease. Am J Dis Child. 1993 Jun;147(6):658–661. doi: 10.1001/archpedi.1993.02160300064024. [DOI] [PubMed] [Google Scholar]
  22. Papile L. A., Tyson J. E., Stoll B. J., Wright L. L., Donovan E. F., Bauer C. R., Krause-Steinrauf H., Verter J., Korones S. B., Lemons J. A. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med. 1998 Apr 16;338(16):1112–1118. doi: 10.1056/NEJM199804163381604. [DOI] [PubMed] [Google Scholar]
  23. Shinwell E. S., Karplus M., Zmora E., Reich D., Rothschild A., Blazer S., Bader D., Yurman S., Dolfin T., Kuint J. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 1996 Jan;74(1):F33–F37. doi: 10.1136/fn.74.1.f33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weichsel M. E., Jr The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurological hazards. Ann Neurol. 1977 Nov;2(5):364–366. doi: 10.1002/ana.410020503. [DOI] [PubMed] [Google Scholar]
  25. Yeh T. F., Torre J. A., Rastogi A., Anyebuno M. A., Pildes R. S. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr. 1990 Aug;117(2 Pt 1):273–282. doi: 10.1016/s0022-3476(05)80547-5. [DOI] [PubMed] [Google Scholar]
  26. Yuksel B., Greenough A. Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up. Thorax. 1992 Nov;47(11):910–913. doi: 10.1136/thx.47.11.910. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES